Highlights
- 1Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2023
Publications
20 publications
Funding
1 grant
Completed grants (1)
- Sub-PIR01AI143910-04Bacterial Characteristics of Community-associated Carbapenem-Resistant EnterobacteriaceaeNational Institute of Allergy and Infectious Diseases · 2020–2024 · via University of North Carolina at Chapel Hill
Clinical research
6 studies
Active
3 studies- PISPIND 183922 ClofazimineNovartis Pharmaceuticals Corporation · OPEN TO ACCRUAL (as of 2026)
- PISPIND 180201 ClofazimineNovartis Pharmaceuticals Corporation · OPEN TO ACCRUAL (as of 2025)
- PINCT03808922A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised SubjectsPHASE3 · Ansun BioPharma, Inc. · OPEN TO ACCRUAL (as of 2020)Lower Respiratory Tract Infection; Parainfluenza; Immunocompromised; COVID-19
Completed & closed trials (3)
- PISPIND 175628 ClofazimineNovartis Pharmaceuticals Corporation · CLOSED TO ACCRUAL (as of 2025)
- PINCT03924934Community-associated Highly-Resistant EnterobacteralesUniversity of North Carolina · IRB STUDY CLOSURE (as of 2023)Enterobacteriaceae Infections; Community-Acquired Infections; Healthcare Associated Infection; Carbapenem-Resistant Enterobacteriaceae Infection
- PIEmergency Use of CefiderocolWeill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2020)